Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Cutaneous T Cell Lymphoma

Edited by Edited by Richard Edelson (Yale University School of Medicine, New Haven, CT; Vincent T. DeVita, Jr.) and Yale University School of Medicine (New Haven, CT)
Cutaneous T Cell Lymphoma

Published: September 2001

Volume 941

Learn More

First identified in 1975, cutaneous T cell lymphoma (CTCL) is a relatively common and dangerous disease which serves as the testing ground for a wide range of immunotherapies. Recently, rapid advances have been made in the understanding of the cellular properties of the malignant cells of CTCL and in the development of therapeutic agents that target CTCL cells. This volume brings together preeminent basic researchers and clinical investigators who work on CTCL from different perspectives, and suggests opportunities for valuable new interdisciplinary collaborations.

This volume is out of print.